ALX Oncology Holdings Inc. ( ALXO) - Stock Earnings
ALXO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
ALXO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -22.8 million USD | — USD |
| 2026Q1 | -17.9 million USD | — USD |
| 2026Q2 | -18.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ALXO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -160.8 million USD | — USD |
| 2024 | -134.9 million USD | — USD |
| 2025 | -101.7 million USD | — USD |
| 2026 Est. | — | — |
ALXO
Price: $1.96
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 63179
Market Capitalization: 268.3 million